☆ 4.3 Article

Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2023)

Related references

Note: Only part of the references are listed.

Review Microbiology

Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms

Qing Han et al.

Summary: Emerging evidence suggests that COVID-19 survivors may experience persistent symptoms for at least 12 months, including fatigue, dyspnea, arthromyalgia, depression, anxiety, memory loss, concentration difficulties, and insomnia. Female patients and those with more severe initial illness are more likely to suffer from long-term sequelae after one year.

PATHOGENS (2022)

Add to Collection

Article Infectious Diseases

Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients

Sven H. Loosen et al.

Summary: Metabolic disorders and obesity are risk factors for long COVID syndrome (LCS). Additionally, age, gender, asthma, depression, and cancer are also associated with the development of LCS.

INFECTION (2022)

Add to Collection

Review Immunology

Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review

Chen Chen et al.

Summary: This study reveals a substantial prevalence of post-COVID-19 condition worldwide. Hospitalized patients have a higher prevalence compared to non-hospitalized ones. Fatigue is the most commonly reported symptom.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil

Daniel A. P. de Miranda et al.

Summary: This study found that the prevalence of long COVID syndrome was 50.2%, with the most common symptoms being fatigue, persistent cough, dyspnea, loss of smell/taste, and frequent headaches. Older patients tended to have more severe symptoms, and the severity determined the duration of symptoms.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2022)

Add to Collection

Article Infectious Diseases

Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil

Jacqueline Ferreira de Oliveira et al.

Summary: The study investigated long-term consequences of COVID-19 in a cohort of hospitalized patients in Brazil, finding that most patients had at least one long COVID symptom, with fatigue being the most common. ICU admission was associated with long COVID.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

Dysregulated naive B cells and de novo autoreactivity in severe COVID-19

Matthew C. Woodruff et al.

Summary: This study demonstrates the origins, breadth, and resolution of autoreactivity in severe COVID-19, with implications for early intervention and the treatment of patients with post-COVID sequelae.

NATURE (2022)

Add to Collection

Article Medicine, General & Internal

Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction

Alna Carolina Mendes Paranhos et al.

Summary: Determining the characteristics, type, and severity of olfactory dysfunction in patients with long COVID is crucial. This study aimed to describe the socio-demographic and clinical features of patients with persistent olfactory dysfunction. The results showed that olfactory dysfunction is one of the most common long-term neurological symptoms of COVID-19, and patients with this condition may experience severe hyposmia or anosmia for more than 1 year from the onset of symptoms.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Infectious Diseases

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Qiutang Xiong et al.

Summary: The study described the common clinical sequelae in COVID-19 survivors discharged from the hospital for more than 3 months, including general symptoms, respiratory symptoms, cardiovascular-related symptoms, psychosocial symptoms, and alopecia. Female patients were more likely to experience physical decline/fatigue, postactivity polypnoea, and alopecia.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Immunology

Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients

Maria Skaalum Petersen et al.

Summary: The study showed that over half of COVID-19 patients still had at least one symptom persisting after an average of 125 days post-symptom onset, with fatigue, loss of smell and taste, and arthralgias being the most prevalent persistent symptoms. At the last follow-up, 46.9% of patients were asymptomatic compared to only 4.4% during the acute phase. Continued monitoring for long COVID is necessary.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study

Cesar Fernandez-de-Las-Penas et al.

Summary: This study found that obesity was associated with a greater number of long-term post-COVID symptoms and poor sleep quality in hospitalised COVID-19 patients, but no significant difference was observed between people with and without obesity in the prevalence of fatigue, dyspnea, anxiety, depression, and limitations of daily living activities.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

Rachael A. Evans et al.

Summary: The study aimed to understand the impact of COVID-19-related hospitalization on health and employment, identify factors associated with recovery, and describe recovery phenotypes. Findings revealed that some patients did not fully recover six months after discharge, with factors such as female sex, middle age, comorbidities, and severe illness contributing to difficulties in recovery. The study also identified four different recovery phenotypes.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

Luc Morin et al.

Summary: After 4 months of hospitalization for COVID-19, a significant proportion of patients reported new symptoms and abnormalities in lung scans were common. Further research is needed to understand the long-term consequences of COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Medicine, General & Internal

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection A Systematic Review

Destin Groff et al.

Summary: This systematic review found that more than half of COVID-19 survivors experienced PASC 6 months after recovery, with the most common effects being functional mobility impairments, pulmonary abnormalities, and mental health disorders.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Add to Collection

Review Medicine, General & Internal

Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis

Cesar Fernandez-de-las-Penas et al.

Summary: This meta-analysis revealed that more than 60% of patients with SARS-CoV-2 infection experienced post-COVID-19 symptoms. Fatigue and dyspnea were the most prevalent post-COVID-19 symptoms, especially at 60 and >= 90 days after onset.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT

Melanie L. Bell et al.

Summary: Clinical presentation, outcomes, and duration of COVID-19 vary greatly among individuals. Most PASC research has focused on hospitalized patients. A population-based study in Arizona found that 68.7% of non-hospitalized individuals experienced PASC symptoms 30 days post-infection, with fatigue, shortness-of-breath, brain fog, and stress/anxiety being the most common symptoms.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Health Care Sciences & Services

Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol

Louise Sigfrid et al.

Summary: This study found that survivors of Covid-19 experienced long-term symptoms, new disability, increased breathlessness, and reduced quality of life. These findings were present in young, previously healthy working age adults, and were most common in younger females.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Respiratory System

Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity

Liam Townsend et al.

Summary: This study reveals that some patients still experience respiratory diseases and subjective symptoms after COVID-19 infection, with ongoing health issues and fatigue often accompanied by a higher perception of exertion. Initial disease severity does not have a strong correlation with persistent respiratory diseases.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Add to Collection

Article Virology

A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex

Fanfan Zeng et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Otorhinolaryngology

Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life

Simone Meini et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2020)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Multidisciplinary Sciences

Sex differences in immune responses that underlie COVID-19 disease outcomes

Takehiro Takahashi et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection

Liam Townsend et al.

PLOS ONE (2020)

Add to Collection

Review Medicine, General & Internal

Chronic fatigue syndrome

JB Prins et al.

LANCET (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.